Old Web
English
Sign In
Acemap
>
Paper
>
PMU73 MONETIZATION OF ADDITIONAL BENEFIT OF ORPHAN DRUGS IN GERMAN ARBITRATION BOARD DECISIONS
PMU73 MONETIZATION OF ADDITIONAL BENEFIT OF ORPHAN DRUGS IN GERMAN ARBITRATION BOARD DECISIONS
2019
N. Ladicke
H Fieke
T. Volmer
Keywords:
Finance
Medicine
Orphan drug
Monetization
Arbitration
Intensive care medicine
German
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]
map